Press Releases

Matexcel Offers a Wide Selection of Natural Materials for Research Needs

Lifeasible Provides Virus-like Particles Production in Plant

Profacgen Provides Data Analysis Service for Biological Discovery

Phase 2/3 trial suggests that AMZELL’s new topical treatment (AMZ001) for the treatment of knee osteoarthritis symptoms is effective

The phase 2/3 trial of AMZ001, a novel once daily topical diclofenac formulation, provides efficacy and safety results in the relief of pain associated with knee osteoarthritis (OA)

Maravai LifeSciences Expands TriLink BioTechnologies CleanCap® mRNA Capping Capacity and Adds New Plasmid DNA Manufacturing

Maravai LifeSciences has expanded TriLink BioTechnologies CleanCap® mRNA capping capacity and added new Plasmid DNA manufacturing. It is TriLink’s second manufacturing expansion within a year and will help meet global demand for research, clinical and GMP grade raw materials as well as research and clinical-grade APIs to include mRNA, self-amplifying RNA and plasmid DNA.

Panthera further extends its network of clinical trial sites with the opening of a clinical trial site in North London in collaboration with Medicus Health Partners

• Panthera’s network of UK clinical trials sites grows to seven with several others in development.

BOC Sciences Launched Its PROTACs Technology Platform to Assist Drug Development

The Chemistry-Focused Technology Platform Is Optimized at Alfa Chemistry

Alfa Chemistry, the US-located chemical supplier, has recently announced that it has finished the optimization work of its chemistry-focused technology platform, which enables the company to offer a comprehensive range of services such as synthetic chemistry, chiral separations, small molecule synthesis, peptide, nucleoside, fluorinated building blocks, milligram preparation, kilogram GLP scale-up, reagent service, and compound management.

AI & Medicine Develops Medical Therapy and Research System to Facilitate Disease Treatment

On August 18, 2020, AI & Medicine, one of the forerunners in the AI-assisted medicine area, announced that it has successfully developed a medical therapy and research system, which can assist in disease treatment, health management, adjuvant therapy, and deep mining of public document databases. The firm is a well-known expert in combining artificial intelligence with drug discovery, personalized healthcare and various other medical applications.

Creative Biostructure Released Fluorescence Resonance Energy Transfer (FRET) Assay

Optogenetics Services Now Available at Profacgen

Matexcel Updated Its Bioglass Products Recently

Lifeasible Offers Customized One-stop Service for Seed Testing

Washington COVID-19 biorepository supports global quest for affordable diagnostics

A global resource for the development and validation of COVID-19 diagnostics

VERICHEM LABORATORIES OFFERS LIQUID STABLE, NIST TRACEABLE, COMBINED CHOLESTEROL/URIC ACID STANDARD REFERENCE KIT

The liquid stable, ready-to-use MATRIX PLUS™ Cholesterol Reference Kit, containing known concentrations of both Cholesterol and Uric Acid, is now available from VERICHEM LABORATORIES.

New study published in the Journal of the National Cancer Institute concludes that Epi proColon® is the test of choice for the millions of individuals not willing to participate in FIT or colonoscopy screening

Bioactive Matrixes Products Covering the Full Range Are Now Available at CD Bioparticles

As an established drug delivery company focusing on the development and production of drug delivery systems, CD Bioparticles has released a variety of bioactive matrixes covering reagents&assays, responsive hydrogels, functional biomatrixes and photocrosslinkable kits.

BioIVT Offers Expedited Delivery of Immune Cell Products for Cell and Gene Therapy Research, Drug Discovery and Diagnostic Development

BioIVT now provides same-day or next-day global delivery of fresh blood and immune cell products from its seven blood donor centers located in the US and UK.

Cala Health Announces Continued Growth and Momentum with Clinical, Product Development, and Management Milestones to Support Cala Trio Therapy for the Treatment of Essential Tremor

Creative Biolabs’ Oncolytic Virus Construction Services Help to Shape the Future of Oncolytic Virotherapy

As a novel strategy for treatment of tumors, oncolytic virotherapy attracts many attention from global researchers. As a world-leading expert in the field of oncolytic virus, Creative Biolabs has executed every strategy to optimize its virus construction services.